Images List Premium Download Classic

Anxiety

Anxiety-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Heterocyclic compounds for the treatment of neurological and psychological disorders
Alkermes Pharma Ireland Limited
June 14, 2018 - N°20180162816

Lactam compounds of formula i and their use for the treatment of neurological and psychiatric disorders including schizophrenia, bipolar disorder, anxiety disorder and insomnia is disclosed.. .
Programmable training system for pets
June 14, 2018 - N°20180160652

The invention is a programmable electronic system that uses voice recordings and playback to modify, reinforce or eliminate multiple, user determinable pet behaviors. The user manually records a multiplicity of individual messages in the pet collar part of the system that either encourage or discourage certain behaviors in the pet or soothe the pet's anxiety.
Piperdinyl nociceptin receptor compounds
Astraea Therapeutics, Llc
June 07, 2018 - N°20180155314

The present invention provides novel piperidinyl-containing nociceptin receptor ligand compounds and pharmaceutical compositions useful in the treatment of neurological diseases and conditions where such ligands mediate the negative effects of the condition. Such neurological diseases and conditions include acute and chronic pain, substance abuse/dependence, alcohol addiction, anxiety, depression, sleep disorders, gastrointestinal disorders, renal disorders, cardiovascular disorders and parkinson's disease..
Anxiety Patent Pack
Download + patent application PDFs
Anxiety Patent Applications
Download + Anxiety-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Anxiety-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Honokiol and magnolol formulations with increased stability and improved uptake, and methods of use thereof
St Ip Holding Ag
May 31, 2018 - N°20180147220

Described herein are formulations and methods for treating, managing, or preventing sleeplessness or restlessness, for increasing focus or concentration, or for decreasing anxiety. The formulations comprise honokiol and magnolol, which are present in magnolia bark extract, in admixture with one or more polyunsaturated fatty acids, such as those found in virgin salmon oil.
Vehicle autonomy level selection based on user context
Nio Usa, Inc.
May 24, 2018 - N°20180141568

Embodiments herein relate to an autonomous vehicle or self-driving vehicle. The level of comfort with autonomous driving offered to the user and the parameters of operation of the autonomous vehicle might increase or decrease a driver's comfort (anxiety) with the vehicle.
Compressed tablet containing cannabidiol, method for its manufacture and use of such tablet in oral ...
May 24, 2018 - N°20180140560

The invention further provides a method for the manufacture of the compressed tablets.. .
Anxiety Patent Pack
Download + patent application PDFs
Anxiety Patent Applications
Download + Anxiety-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Anxiety-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Ethynyl derivatives
May 10, 2018 - N°20180127429

The compounds may be used for the treatment of parkinson's disease, anxiety, emesis, obsessive compulsive disorder, autism, neuroprotection, cancer, depression and diabetes type 2.. .
Phenyl-piperazine derivatives as serotonin reuptake inhibitors
May 10, 2018 - N°20180127389

Wherein the substituents are defined in the application. The compounds are useful in the treatment of an affective disorder, including depression, anxiety disorders including general anxiety disorder and panic disorder and obsessive compulsive disorder..
Novel composition of nigella sativaseeds to treat anxiety, stress and sleep disorders with significant memory ...
Akay Flavours & Aromatics Pvt Ltd.
May 10, 2018 - N°20180125914

The present invention relates to novel black cumin extract compositions and a green process for making the composition. The black cumin extract composition of the invention can be used to treat anxiety, sleep and stress disorders along with significant effect on memory enhancement.
Imidazo isoindole derivative, preparation method therefor and medical use thereof
Shanghai Hengrui Pharmaceutical Co., Ltd.
May 03, 2018 - N°20180118750

The present invention relates to an imidazo isoindole derivative, a preparation method therefor and a medical use thereof. In particular, the present invention relates to the imidazo isoindole derivative as shown in the formula (i), a preparation method and pharmaceutical composition containing the derivative, and a use thereof for treating diseases with a pathological characteristic of the ido-mediated tryptophan metabolic ...
Pde10 inhibitors and related compositions and methods
Omeros Corporation
May 03, 2018 - N°20180118711

Compounds that inhibit pde10 are disclosed that have utility in the treatment of a variety of conditions, including (but not limited to) psychotic, anxiety, movement disorders and/or neurological disorders such as parkinson's disease, huntington's disease, alzheimer's disease, encephalitis, phobias, epilepsy, aphasia, bell's palsy, cerebral palsy, sleep disorders, pain, tourette's syndrome, schizophrenia, delusional disorders, drug-induced psychosis and panic and obsessive-compulsive ...
Novel anxiolytic compounds
April 19, 2018 - N°20180105524

Which may possess useful therapeutic activity in a range of central nervous system disorders, and in particular, anxiety disorders.. .
Novel anxiolytic compounds
April 19, 2018 - N°20180105523

Which may possess useful therapeutic activity in a range of central nervous system disorders, and in particular, anxiety disorders.. .
Anxiety Patent Pack
Download + patent application PDFs
Anxiety Patent Applications
Download + Anxiety-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Anxiety-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Compositions and methods for treatment of fragile x syndrome
Children's Hospital Medical Center
April 19, 2018 - N°20180104244

Disclosed are methods of alleviating or preventing one or more symptoms associated with fragile x syndrome in an individual in need thereof via administration of a therapeutically effective amount of a gaba(a) alpha 2 and/or 3 partial agonist. The one or more symptoms may include impaired functional communication, anxiety, inattention, hyperactivity, sensory reactivity, autonomic nervous system dysregulation, aberrant eye gaze, ...
Novel kappa opioid ligands
The Scripps Research Institute
April 12, 2018 - N°20180099954

The invention provides novel ligands of kappa (κ) opioid receptors, such as can be used to modulate a kappa opioid receptor. Methods of synthesis and methods of use are also provided.
Airborne anxiety detection and remediation
International Business Machines Corporation
April 12, 2018 - N°20180099115

Embodiments include methods, systems, and computer program products for detection and remediation of anxiety. Aspects include receiving an anxiety indicator.
Methods of treating depression and other related diseases
Northwestern University
April 05, 2018 - N°20180094026

The invention relates to methods for treating depression, anxiety, and other related diseases by administering a peptide nmdar partial agonist.. .
Ethynyl derivatives
March 29, 2018 - N°20180086680

Compounds of formula i are metabotropic glutamate receptor antagonists (negative allosteric modulators) for use in the treatment of, e.g., anxiety and pain, depression, fragile-x syndrome, autism spectrum disorders, parkinson's disease, and gastroesophageal reflux disease (gerd).. .
Device for the reduction of inhaled carbon dioxide
March 29, 2018 - N°20180085548

Anxiety attacks can often be limited or eliminated by reducing the concentration of inhaled carbon dioxide. Disclosed is a handheld device for reducing the carbon dioxide concentration of inhaled air by using stacked sheets having rows of adsorbents deposited thereon and which form a removable cartridge.
Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity
Auspex Pharmaceuticals, Inc.
March 29, 2018 - N°20180085327

Chemical syntheses and medical uses of novel inhibitors of the uptake of monoamine neurotransmitters and pharmaceutically acceptable salts and prodrugs thereof, for the treatment and/or management of psychotropic disorders, anxiety disorder, generalized anxiety disorder, depression, post-traumatic stress disorder, obsessive-compulsive disorder, panic disorder, hot flashes, senile dementia, migraine, hepatopulmonary syndrome, chronic pain, nociceptive pain, neuropathic pain, painful diabetic retinopathy, bipolar ...
Trpv3 agonists for the treatment of skin conditions
March 29, 2018 - N°20180085296

Described are methods and uses of trpv3 agonists for the treatment of conditions associated with trpv3 pathophysiology such as acne, psoriasis, dermatitis, would healing, the inhibition of hair growth, anxiety or depression. Peptides comprising all or part of the c-terminal portion of soricidin are shown to activate trpv3 cation channel activity and/or promote wound healing in keratinocytes..
Loading